Financials in USD. Standardized financial statements.
A compact view of how Quantum Genomics S.A. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $10 | $19,796 | $2.52M | $5.80M | $1.83M | $1.55M | $3,686 | $0 | $0 | $144,138 |
| Revenue Growth? | -99.9% | -99.2% | -56.6% | +217.1% | +18.2% | +41869.6% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $1.15M | $1.44M | $29.50M | $20.34M | $16.73M | $12,025 | $19,018 | $25,868 | $3.87M | $2.77M |
| Gross Profit? | -$1.15M | -$1.42M | -$26.99M | -$17.21M | -$14.90M | $1.53M | -$15,332 | -$25,868 | -$3.87M | -$2.62M |
| Gross Margin? | -11453070.0% | -7169.6% | -1073.0% | -296.7% | -814.9% | +99.2% | -416.0% | 0.0% | 0.0% | -1819.1% |
| Operating Expenses? | $327,528 | $1.72M | $3.10M | $2.91M | $1.93M | $10.75M | $13.58M | $10.27M | $2.34M | $1.66M |
| Operating Income? | -$1.47M | -$3.14M | -$30.08M | -$17.09M | -$14.68M | -$10.76M | -$13.60M | -$10.29M | -$6.22M | -$4.31M |
| EBITDA? | -$1.47M | -$2.87M | -$29.82M | -$19.41M | -$14.67M | -$10.61M | -$13.55M | -$10.27M | -$6.19M | -$4.26M |
| Income Before Tax | -$8.89M | -$3.21M | -$27.48M | -$17.19M | -$18.29M | -$10.63M | -$13.45M | -$10.53M | -$6.20M | -$4.48M |
| Income Tax Expense | $0 | -$34,431 | -$2.55M | $170,000 | -$2.07M | -$1.55M | -$1.46M | -$1.15M | -$957,927 | -$713,844 |
| Net Income? | -$8.89M | -$3.17M | -$24.94M | -$17.36M | -$16.22M | -$9.08M | -$11.99M | -$9.38M | -$5.24M | -$3.76M |
| EPS? | $-0.13 | $-0.09 | $-0.72 | $-0.61 | $-0.79 | $-0.50 | $-0.76 | $-0.86 | $-0.63 | $-0.54 |
| Diluted EPS? | $-0.13 | $-0.09 | $-0.72 | $-0.61 | $-0.79 | $-0.50 | $-0.76 | $-0.86 | $-0.63 | $-0.54 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality